RemedyRepack Recalls Ranitidine Tablets Due to Potential NDMA Contamination
RemedyRepack Inc. is recalling specific lots of Ranitidine 150 mg tablets because the supplier reported potential Nitrosodimethylamine (NDMA) levels above established limits.
- Product
- Ranitidine 150 mg tablet Original Supplier's NDC 65162-0253-10 Remedy Repackaged NDC 70518-1714-00
- Category
- Drug
- Distribution
- 2 states